Understanding PPM1D Gene Changes in Blood Cancers
Role of PPM1D and PPM1D mutations in hematopoiesis and response to stress
This project explores how changes in a gene called PPM1D affect blood cell development and how these changes might lead to certain blood cancers, especially after chemotherapy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11159383 on NIH RePORTER |
What this research studies
Our bodies have a gene called PPM1D, which can sometimes be altered in various cancers. When PPM1D is changed, it can lead to higher levels of a specific protein, which is often seen in conditions like clonal hematopoiesis and certain blood cancers that develop after chemotherapy. We are using new laboratory models to understand how these PPM1D changes impact the healthy production of blood cells and how they respond to stress, such as radiation or inflammation. We also want to discover the natural processes that control PPM1D levels in the body, which could help us find new ways to target this gene for treatment.
Who could benefit from this research
Good fit: Patients with clonal hematopoiesis, myeloid malignancies, or those who have received chemotherapy and are at risk for related blood disorders might be interested in the future implications of this research.
Not a fit: Patients without conditions related to PPM1D mutations, clonal hematopoiesis, or myeloid malignancies would likely not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat blood cancers, particularly those linked to chemotherapy, by targeting the PPM1D gene.
How similar studies have performed: This project uses novel mouse models and genetic screens to explore mechanisms that are not yet fully understood, building on existing knowledge about PPM1D's role in cancer.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Miller, Peter Grant — Massachusetts General Hospital
- Study coordinator: Miller, Peter Grant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.